Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-15-007900
Filing Date
2015-09-24
Accepted
2015-09-24 16:31:45
Documents
5
Period of Report
2015-11-09
Effectiveness Date
2015-09-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1502205-def14a.htm DEF 14A 481033
2 GRAPHIC lg_phibrocorp-cmyk.jpg GRAPHIC 177114
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
4 GRAPHIC t1502205_pc-01.jpg GRAPHIC 294553
5 GRAPHIC t1502205_pc-02.jpg GRAPHIC 203693
  Complete submission text file 0001571049-15-007900.txt   1412548
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 151123348
SIC: 2834 Pharmaceutical Preparations